Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
deals
3
×
life sciences
national blog main
medical devices
san francisco
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
10x genomics
alivecor
alphabet
aperture venture partners
aphelion capital
arrythmia
ascension ventures
astellas pharma
bardy diagnostics
becton dickinson
boston blog main
boston scientific
boston top stories
broad institute of harvard and mit
brook byers
cam
cameron health
cancer
cancer diagnostics
cardiology
carnation ambulatory monitor
charles chu
crispr
crispr cas14
decheng capital
diagnostic
diagnostic device
google
gust bardy
What
diagnostics
3
×
based
adding
aims
arrhythmia
available
bardy
big
bio
biosciences
business
cardiac
cas
cheaper
company
crispr
deal
decisions
detection
develop
developing
device
diagnostic
expand
expects
faster
fold
help
make
mammoth
million
monitor
nanostring
physicians
raise
raised
ramp
reach
sales
seattle
Language
unset
Current search:
diagnostics
×
deals
×
@xconomy.com
4 years ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
@xconomy.com
4 years ago
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
@xconomy.com
5 years ago
Bardy Diagnostics to Ramp Up Cardiac Monitor Sales With $35M Raise
